An international pharmaceutical industrial complex focused on biopharmaceuticals and export to global markets — a very large-scale project, comparable to the complexes of major global companies.
Total investment: approximately $2 to $5 billion for a modern, internationally competitive complex.
Production of monoclonal antibodies (mAbs)
Production of recombinant drugs
Production of new-generation vaccines
Production of cellular & gene drugs
Research & Development (R&D) center
Clinical trial center
Quality control center to international standards
Specialized training center
Distribution & export center with cold chain
Dedicated power plant & ultrapure water system
Direct personnel — pharmacists, biotechnologists, process engineers, quality specialists, researchers and international managers.
Indirect jobs created across the supply chain and surrounding economy.
To export to global markets, the complex must operate in accordance with the requirements of reputable institutions.
Master planning, engineering and regulatory groundwork.
Buildings, production lines and specialized facilities come online.
Regulatory validation and licensing ahead of commercial operation.
Reach out to the AFRA Holding team to discuss this venture in more detail.